Your browser doesn't support javascript.
Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study.
Jenney, Adam; Chibo, Doris; Batty, Mitch; Druce, Julian; Melvin, Robert; Stewardson, Andrew; Dennison, Amanda; Symes, Sally; Kinsella, Paul; Tran, Thomas; Mackenzie, Charlene; Johnson, Douglas; Thevarajan, Irani; McGrath, Christian; Matlock, Amelia; Prestedge, Jacqueline; Gooey, Megan; Roney, Janine; Bobbitt, Joanne; Yallop, Sarah; Catton, Mike; Williamson, Deborah A.
  • Jenney A; Microbiology Unit, Alfred Hospital, Melbourne, Victoria, Australia.
  • Chibo D; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Batty M; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Druce J; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Melvin R; Hotel Support Services, Alfred Hospital, Melbourne, Victoria, Australia.
  • Stewardson A; Department of Infectious Diseases, Alfred Hospital, Melbourne, Victoria, Australia.
  • Dennison A; Microbiology Unit, Alfred Hospital, Melbourne, Victoria, Australia.
  • Symes S; Pathology, Engagement and Testing, Victorian Department of Health, Melbourne, Victoria, Australia.
  • Kinsella P; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Tran T; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Mackenzie C; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Johnson D; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Thevarajan I; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia.
  • McGrath C; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Matlock A; Department of Infectious Diseases, Northern Health, Melbourne, Victoria, Australia.
  • Prestedge J; Pathology, Engagement and Testing, Victorian Department of Health, Melbourne, Victoria, Australia.
  • Gooey M; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Roney J; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Bobbitt J; Clinical Research Unit, Department of Infectious Diseases, Alfred Hospital, Melbourne, Victoria, Australia.
  • Yallop S; Pathology, Engagement and Testing, Victorian Department of Health, Melbourne, Victoria, Australia.
  • Catton M; Pathology, Engagement and Testing, Victorian Department of Health, Melbourne, Victoria, Australia.
  • Williamson DA; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Lancet Reg Health West Pac ; 26: 100533, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-2086523
ABSTRACT

Background:

Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for regular testing. In this multi-centre evaluation, we aimed to validate RT-PCR using salivary swab testing of SARS-CoV-2 for large-scale surveillance testing and assess implementation amongst staff working in the hotel quarantine system in Victoria, Australia.

Methods:

A multi-centre laboratory evaluation study was conducted to systematically validate the in vitro and clinical performance of salivary swab RT-PCR for implementation of SARS-CoV-2 surveillance testing. Analytical sensitivity for multiple RT-PCR platforms was assessed using a dilution series of known SARS-CoV-2 viral loads, and assay specificity was examined using a panel of viral pathogens other than SARS-CoV-2. In addition, we tested capacity for large-scale saliva testing using a four-sample pooling approach, where positive pools were subsequently decoupled and retested. Regular, frequent self-collected saliva swab RT-PCR testing was implemented for staff across fourteen quarantine hotels. Samples were tested at three diagnostic laboratories validated in this study, and results were provided back to staff in real-time.

Findings:

The agreement of self-collected saliva swabs for RT-PCR was 84.5% (95% CI 68.6 to 93.8) compared to RT-PCR using nasal/oropharyngeal swab samples collected by a healthcare practitioner, when saliva samples were collected within seven days of symptom onset. Between 7th December 2020 and 17th December 2021, almost 500,000 RT-PCR tests were performed on saliva swabs self-collected by 102 staff working in quarantine hotels in Melbourne. Of these, 20 positive saliva swabs were produced by 13 staff (0.004%). The majority of staff that tested positive occurred during periods of community transmission of the SARS-CoV-2 Delta variant.

Interpretation:

Salivary RT-PCR had an acceptable level of agreement compared to standard nasal/oropharyngeal swab RT-PCR within early symptom onset. The scalability, tolerability and ease of self-collection highlights utility for frequent or repeated testing in high-risk settings, such as quarantine or healthcare environments where regular monitoring of staff is critical for public health, and protection of vulnerable populations.

Funding:

This work was funded by the Victorian Department of Health.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Variants Language: English Journal: Lancet Reg Health West Pac Year: 2022 Document Type: Article Affiliation country: J.lanwpc.2022.100533

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Variants Language: English Journal: Lancet Reg Health West Pac Year: 2022 Document Type: Article Affiliation country: J.lanwpc.2022.100533